1. Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial. Issue 5 (May 2019) Authors: Makker, Vicky; Rasco, Drew; Vogelzang, Nicholas J; Brose, Marcia S; Cohn, Allen L; Mier, James; Di Simone, Christopher; Hyman, David M; Stepan, Daniel E; Dutcus, Corina E; Schmidt, Emmett V; Guo, Matthew; Sachdev, Pallavi; Shumaker, Robert; Aghajanian, Carol; Taylor, Matthew Journal: Lancet oncology Issue: Volume 20:Issue 5(2019) Page Start: 711 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗